Delivery Order SPE2DB22D2214-SPE2DB25FS6FC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,451.16 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,845.42 on August 5, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,721.82 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for OxyContin ER 10 mg tablets (100-count units) valued at $1,494.12. This is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, to be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating it was competitively awarded. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,208.27 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100-count) valued at $1,908.93, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,194.12 on August 14, 2025, for OxyContin ER 30 mg tablets (100-count supply). This firm fixed price, non-set-aside contract is part of AmerisourceBergen's broader engagement with the DLA and represents a delivery order issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) valued at $1,228.74, with a firm fixed price arrangement and an ultimate completion date of July 31, 2025. This non-set-aside, competitively awarded contract represents a single delivery order executed on July 30, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,125.41 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100 count) on August 20, 2025, with completion scheduled for August 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) valued at $1,458.52, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction under the contractor's larger pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's corporate office...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6FCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,967.11 to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100 count) on August 20, 2025, with completion scheduled for August 21, 2025. This is a firm fixed-price, non-set-aside contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive IDC vehicle that enables supply of pharmaceuticals and medical products to support military healthcare programs globally. The company has demonstrated its capability to meet federal procurement requirements through competitive awards across multiple therapeutic domains, including pain management pharmaceuticals, and continues to serve the Defense Health Agency and other government healthcare systems through flexible contract mechanisms. This delivery order represents a routine pharmaceutical transaction within the scope of the broader strategic pharmaceutical support arrangement between DLA and the contractor.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/20/25 |